Discovery and Development of 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Bcl-2/Mcl-1 Inhibitors

Renshuai Liu,Lulu Liu,Xinying Yang,Hao Fang
DOI: https://doi.org/10.1016/j.bioorg.2019.102938
IF: 5.307
2019-01-01
Bioorganic Chemistry
Abstract:Bcl-2 family proteins play a vital role for cancer cell in escaping apoptosis, and small-molecule anti-apoptotic Bcl-2 protein inhibitors have been developed as new anticancer therapies. In current study, a series of substituted 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives were developed based on the lead compound 1 (K-i = 5.2 mu M against Bcl-2 protein). The fluorescence polarization assays suggested that active compounds possessed potent binding affinities to both Bcl-2 and Mcl-1 protein, but had minor or no binding affinities to Bcl-X-L protein. MTT assays showed that these compounds had certain anti-proliferative activities against cancer cells. Furthermore, it was found that active compound 11t could induce cell apoptosis and caspase-3 activation in a dose-dependent manner in Jurkat cells.
What problem does this paper attempt to address?